1992
DOI: 10.1159/000118813
|View full text |Cite
|
Sign up to set email alerts
|

Serotonergic Inhibition of Limbic and Thalamic Seizures in Cats

Abstract: To clarify the role of the serotonergic system in limbic and thalamic epileptic activity, we examined the effects of 5-hydroxytryρtophan (5-HTP, 20 and 40 mg/kg) on fully kindled seizures from the hippocampus and lateral geniculate nucleus. The intraperitoneal administration of 20 mg/kg 5-HTP exerted no anticonvulsant effect on hippocampal kindled seizures, and a higher dose (40 mg/kg) produced a signiñcant reduction in the behavioral seizure stage. 5-HTP at 20 mg/kg displayed no suppressive effect on lateral … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1992
1992
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…The administration of 5-HT receptor agonists or reuptake inhibitors tends to inhibit limbic and generalized seizures [142-144]. Wada et al ., (1992) recited that 5-HTP (the serotonin precursor) has a potent antiepileptic action as regards to hippocampal and lateral geniculate nucleus-kindled seizures, implying that the serotonergic system is entangled in the abolishment of epileptic activity in these brain areas [145]. In addition, patients with myoclonus had low cerebrospinal levels of 5-Hydroxyindoleacetic acid (5-HIAA; the main metabolite of serotonin) indicating that some forms of myoclonus might be pertinent to a dearth of brain serotonin [146].…”
Section: Serotoninmentioning
confidence: 99%
“…The administration of 5-HT receptor agonists or reuptake inhibitors tends to inhibit limbic and generalized seizures [142-144]. Wada et al ., (1992) recited that 5-HTP (the serotonin precursor) has a potent antiepileptic action as regards to hippocampal and lateral geniculate nucleus-kindled seizures, implying that the serotonergic system is entangled in the abolishment of epileptic activity in these brain areas [145]. In addition, patients with myoclonus had low cerebrospinal levels of 5-Hydroxyindoleacetic acid (5-HIAA; the main metabolite of serotonin) indicating that some forms of myoclonus might be pertinent to a dearth of brain serotonin [146].…”
Section: Serotoninmentioning
confidence: 99%
“…We suggest that the release of serotonin by CBZ contributes to the therapeutic actions of CBZ. Increasing serotonin release causes anticonvulsant effects in most animal seizure models, including maximal electroshock in rats and mice (21-23), sensory-induced seizures in El mice (24), limbic and thalamic seizures in cats (25,26), audiogenic seizures in GEPRs (27-3 l), audiogenic seizures in DBA mice (32), and in seizures induced by focal injection of bicuculine into the area tempestis of the deep prepiriform cortex in rats (33,34). Depletion of brain serotonin in GEPRs decreases the anticonvulsant effectiveness of CBZ and other AEDs that release serotonin but does not alter the anticonvulsant activity of PHT, a drug that does not release serotonin (4,7).…”
Section: Fraction Numbermentioning
confidence: 99%